Nektar Therapeutics | NKTR - Cost Of Sales

Nektar Therapeutics reported $6.23M in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Agios Pharmaceuticals AGIO:US USD 413K 104K
ALKERMES ALKS:US USD 53.96M 3.34M
Amgen AMGN:US USD 1.75B 159M
Astrazeneca AZN:US USD 2.51B 393M
Baxter International BAX:US USD 2.42B 208M
Biocryst Pharmaceuticals BCRX:US USD 2.5M 1.12M
Biogen BIIB:US USD 570.9M 101.4M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Cara Therapeutics CARA:US USD 2.13M 925K
Dr.Reddys Laboratories DRRD:IN INR 20.01B 1.54B
Eisai 4523:JP JPY 46.74B 1.6B
Eli Lilly And LLY:US USD 1.55B 31M
Esperion Therapeutics ESPR:US USD 4.16M 2.35M
Exelixis EXEL:US USD 15.92M 615K
Gilead Sciences GILD:US USD 1.4B 1000K
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Halozyme Therapeutics HALO:US USD 42.12M 5.2M
IONIS PHARMACEUT IONS:US USD 3.69M 2.17M
Karyopharm Therapeutics KPTI:US USD 1.87M 888K
MacroGenics MGNX:US USD 1.79M 1.35M
Merk MRK:US USD 3.36B 519M
Nektar Therapeutics NKTR:US USD 6.23M 1.26M
Neurocrine Biosciences NBIX:US USD 7.7M 1.6M
Novartis NOVN:VX USD 3.84B 180M
Pfizer PFE:US USD 9.82B 3.73B
Roche Holding ROG:VX 8.95B 613M
Sarepta Therapeutics SRPT:US USD 30.8M 9.15M
Seattle Genetics SGEN:US USD 108.21M 88K
Takeda 4502:JP JPY 335.97B 30.53B
Teva Pharmaceutical TEVA:IT USD 1.78B 101M
YTE INCY:US USD 53.76M 4.48M